Trials / Unknown
UnknownNCT01300078
A Clinical Trial Assessing Safety of MF101 for Hot Flushes
A Phase 1 Open Label, Randomized Clinical Trial Assessing Safety of MF101 for Hot Flushes and Menopausal Symptoms in Postmenopausal Women
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Bionovo · Industry
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This Phase 1, open label, randomized clinical trial will enroll 40 generally healthy, postmenopausal women aged 40-65 years old. Women will be randomized to one of two oral doses of MF101 for 4 weeks. Participants will be recruited at 3 clinical sites in the United States.
Detailed description
MF101 is an oral, non-hormonal, botanical agent being investigated for the treatment of menopausal hot flashes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MF101 | MF101 10 g/day MF101 15 g/day |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2011-02-21
- Last updated
- 2011-06-02
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01300078. Inclusion in this directory is not an endorsement.